Weight Loss Medications
Understanding Weight Loss Drugs
Weight loss drugs have advanced significantly in recent years as obesity and metabolic health concerns continue to affect individuals throughout Sarasota and across Florida.
Prescription weight loss medications can support long-term weight management when used alongside lifestyle changes. These medications work through different pathways that affect appetite, fullness, cravings, digestion, and metabolism.
Available options now include both weight loss injections and weight loss pills, allowing treatment to be tailored to individual needs and preferences.
These medications are not simply focused on cosmetic weight loss. Instead, they may help improve obesity-related health conditions such as type 2 diabetes, cardiovascular disease, sleep apnea, fatty liver disease, and metabolic dysfunction.
At Solstice Health & Wellness, medical weight loss is approached through an integrated model that combines nutrition, physical activity, behavioral support, primary care, and long-term wellness strategies.
Weight management often intersects with stress, mental health, sleep, substance use, emotional eating, and overall lifestyle health. Therefore, treatment plans focus on the whole person rather than weight alone.
FDA-Approved Weight Loss Medications
Recent FDA-approved weight loss drugs have expanded treatment options for obesity and other health conditions. Today’s prescription obesity medications include both oral weight loss pills and injectable therapies.
Some medications primarily target gut hormone pathways, while others affect brain pathways involved in hunger, reward, and impulse control.
In particular, GLP-1 weight loss injections and newer dual-hormone therapies have transformed medical weight loss treatment by reducing appetite, slowing gastric emptying, and improving metabolic function.
Prescription Weight Loss Medications
Prescription weight loss medications can support long-term weight management when used alongside nutrition, physical activity, behavioral support, sleep, and other lifestyle changes. These medications work through different pathways that affect appetite, fullness, cravings, digestion, metabolism, and energy balance.
Some medications primarily target gut hormone pathways, while others affect brain pathways involved in hunger, reward, and impulse control. Treatment should be individualized based on medical history, metabolic health, eating behaviors, co-occurring conditions, and personal goals.
GLP-1 & Incretin-Based Weight Loss Medications
GLP-1 and incretin-based therapies mimic natural gut hormones that regulate appetite, fullness, blood sugar control, and metabolic health. They help reduce hunger, delay stomach emptying, improve insulin signaling, and support meaningful weight loss.
Shared GLP-1 Side Effects: Nausea, constipation, diarrhea, vomiting, bloating, stomach discomfort, acid reflux, gas, headache, fatigue, and dizziness. These symptoms are most common during dose increases and usually improve over time.
Who Should Not Take These Medications: These medications should not be used by people with a personal or family history of medullary thyroid cancer (MTC) or MEN2, or by those with a serious allergy to the specific medication.
Use caution in people with severe gastroparesis, a history of pancreatitis, gallbladder disease, kidney problems, or diabetic eye disease. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding.
The shared side effects and precautions above apply to all four GLP-1 medications below. Only additional medication-specific information is listed under each.
Orforglipron (Foundayo)
Class: Oral GLP-1 Receptor Agonist
How It’s Taken: Once-daily oral tablet. It does not need to be taken on an empty stomach or with a limited amount of water.
How It Works: Orforglipron activates GLP-1 receptors to reduce hunger, improve fullness, and slow stomach emptying.
Side Effects: See shared GLP-1 side effects above. Additional side effects include hair loss and burping.
Who Should Not Take It: See shared GLP-1 precautions above.
Key Benefits: Weight loss exceeding 11% at 72 weeks in clinical trials.
Special Notes: Can be taken with or without food and without water restrictions. Approved April 2026.
Tirzepatide (Zepbound)
Class: Dual GIP/GLP-1 Receptor Agonist
How It’s Taken: Once-weekly subcutaneous injection.
How It Works: Tirzepatide activates both GLP-1 and GIP pathways to produce greater weight loss and improve blood sugar and metabolic function.
Side Effects: See shared GLP-1 side effects above. Additional side effects include injection site reactions.
Who Should Not Take It: See shared GLP-1 precautions above. Tirzepatide reduces the effectiveness of oral birth control. Non-oral contraception or a barrier method is advised for the first 4 weeks after starting and after each dose increase.
Key Benefits: Average weight loss of 20.9% at 72 weeks in clinical trials. Also FDA-approved for obstructive sleep apnea.
Special Notes: Dual hormone pathway activation differentiates it from GLP-1-only medications. Currently, the most effective FDA-approved weight loss drug.
Semaglutide (Wegovy)
Class: GLP-1 Receptor Agonist
How It’s Taken: Once-weekly subcutaneous injection OR once-daily oral tablet (25 mg). Take the tablet on an empty stomach with no more than 4 ounces of water; wait at least 30 minutes before eating, drinking, or taking other oral medications.
How It Works: Semaglutide activates GLP-1 receptors to regulate appetite, fullness, and food cravings while slowing stomach emptying. It has also been shown to reduce the risk of heart attacks and strokes in people with obesity and cardiovascular disease.
Side Effects: See shared GLP-1 side effects above. Additional side effects include injection site reactions (injection form) and hair loss.
Who Should Not Take It: See shared GLP-1 precautions above.
Key Benefits: Average weight loss of 13-15% at just over 60 weeks in clinical trials. Also FDA-approved for cardiovascular risk reduction in people with obesity and heart disease, and for metabolic fatty liver disease with fibrosis.
Special Notes: The first GLP-1 agonist approved for weight loss in Dec 2025.
Liraglutide (Saxenda)
Class: GLP-1 Receptor Agonist
How It’s Taken: Once-daily subcutaneous injection.
How It Works: Liraglutide activates GLP-1 receptors to reduce appetite, improve fullness, slow stomach emptying, and help regulate blood sugar.
Side Effects: See shared GLP-1 side effects above. Additional side effects include increased heart rate, low blood sugar (especially in people with diabetes), and injection site reactions.
Who Should Not Take It: See shared GLP-1 precautions above.
Key Benefits: Approximately 5-8% weight loss in clinical trials. Also approved for adolescents aged 12 and older.
Special Notes: It was one of the first GLP-1 medications approved for weight management.
Appetite and Craving Control Medications
These medications primarily affect brain pathways involved in appetite, cravings, reward, emotional eating, and impulse control. Some may also overlap with pathways involved in compulsive eating behaviors and addiction.
Naltrexone-Bupropion (Contrave)
Class: Combination Appetite and Reward Pathway Medication
How It’s Taken: Oral tablets, taken twice daily. The dose is gradually increased over 4 weeks to the full maintenance dose.
How It Works: Contrave combines naltrexone and bupropion, which work together in the brain. Bupropion increases dopamine and norepinephrine activity to reduce appetite and food cravings. Naltrexone blocks opioid receptors in the brain’s reward system, reducing reward-driven and emotional eating.
Side Effects: Nausea (the most common reason people stop taking it), constipation, headache, vomiting, dizziness, dry mouth, trouble sleeping, and diarrhea. Blood pressure and heart rate may increase.
Who Should Not Take It: People with uncontrolled high blood pressure, seizure disorders, a history of anorexia nervosa or bulimia nervosa, current opioid use, recent opioid withdrawal, or recent use of MAO inhibitor medications. People undergoing abrupt discontinuation of alcohol, benzodiazepines, or anti-seizure medications should also avoid this medication. Use caution in people with liver disease, depression, or suicidal thoughts. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Key Benefits: Approximately 5-6% weight loss in clinical trials. Targets both appetite and emotional/reward-driven eating.
Special Notes: Nausea is the most common reason people stop taking this medication.
Phentermine-Topiramate (Qsymia)
Class: Combination Appetite Suppression Medication
How It’s Taken: Oral capsule, taken once daily in the morning. The dose is gradually increased. Must be tapered gradually when stopping — do not discontinue suddenly.
How It Works: Qsymia combines phentermine and topiramate. Phentermine has stimulant-like effects that suppress appetite by increasing norepinephrine in the brain. Topiramate affects multiple brain pathways involved in appetite regulation, including GABA and glutamate signaling. Together, they produce greater weight loss than either medication alone.
Side Effects: Tingling or numbness in hands and feet, dizziness, altered taste, constipation, dry mouth, trouble sleeping, difficulty concentrating or finding words, and increased heart rate.
Who Should Not Take It: Women who are pregnant or planning to become pregnant — topiramate can cause serious birth defects (monthly pregnancy tests are required). Also not appropriate for people with glaucoma, hyperthyroidism, or recent MAO inhibitor use. Use caution in people with kidney stones, metabolic acidosis, depression, or suicidal thoughts. Tell your doctor if you are breastfeeding.
Key Benefits: Approximately 8-10% weight loss in clinical trials. FDA-approved for chronic weight management in adults with obesity. Combination produces greater weight loss than either medication alone.
Special Notes: Must be tapered gradually when stopping to avoid seizures. Monthly pregnancy tests required.
Phentermine (Adipex-P, Lomaira)
Class: Sympathomimetic Amine (Appetite Suppression)
How It’s Taken: Oral tablet or capsule, taken once daily (or in divided doses). Generally approved for short-term use (up to 12 weeks).
How It Works: Phentermine is a stimulant-like medication that suppresses appetite by increasing norepinephrine activity in the brain. It is one of the oldest and most commonly prescribed weight loss medications.
Side Effects: Dry mouth, trouble sleeping, dizziness, irritability, nausea, constipation, elevated heart rate, elevated blood pressure, restlessness, and anxiety.
Who Should Not Take It: People with heart disease (including coronary artery disease, heart failure, arrhythmias, or stroke), uncontrolled high blood pressure, hyperthyroidism, glaucoma, agitation, a history of substance use disorder, or recent MAO inhibitor use. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Key Benefits: Approximately 5-6% weight loss in clinical trials. FDA-approved for short-term weight management in adults with obesity. Least expensive prescription weight loss medication available.
Special Notes: Generally approved for short-term use only (up to 12 weeks), though some doctors prescribe it for longer periods off-label.
Fat Absorption Weight Loss Medication
Unlike most prescription weight loss medications, fat absorption medications work within the digestive tract rather than through appetite or brain signaling pathways.
Orlistat (Xenical / Alli)
Class: Lipase Inhibitor (Fat Absorption Blocker)
How It’s Taken: Oral capsule, taken with each meal containing fat (up to 3 times daily). Xenical (120 mg) requires a prescription; Alli (60 mg) is available over the counter. A daily multivitamin should be taken at bedtime, at least 2 hours apart from orlistat.
How It Works: Orlistat blocks digestive enzymes (lipases) that break down dietary fat, preventing approximately 30% of dietary fat from being absorbed. The undigested fat passes through the body. It does not affect appetite or brain signaling.
Side Effects: Oily or fatty stools, oily spotting on underwear, gas with oily discharge, frequent bowel movements, difficulty controlling bowel movements, and stomach discomfort. These effects are directly related to undigested fat and are worse after high-fat meals — eating a lower-fat diet significantly reduces them. Orlistat may also reduce the absorption of fat-soluble vitamins (A, D, E, and K).
Who Should Not Take It: People who have had an organ transplant (orlistat interferes with anti-rejection medications such as cyclosporine), people with chronic malabsorption syndrome, cholestasis, or a known allergy to orlistat. Use caution in people with kidney stones, gallbladder disease, pancreatitis, or liver disease. Tell your doctor if you take blood thinners, thyroid medication, seizure medication, or diabetes medication, as doses may need adjustment. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding.
Key Benefits: Approximately 3% weight loss in clinical trials. FDA-approved for weight management in adults with obesity. Only weight loss medication that works by blocking fat absorption rather than affecting appetite.
Special Notes: Results are directly related to dietary fat intake. Taking a lower-fat diet significantly reduces side effects.
Important Safety Considerations
Prescription weight loss medications are not appropriate for everyone and require individualized medical evaluation. Some medications may interact with psychiatric medications, diabetes medications, seizure medications, opioids, or hormonal contraceptives.
Additionally, pregnancy, eating disorders, pancreatitis history, cardiovascular disease, and substance use disorders may affect medication selection.
Although these medications can provide meaningful weight loss and metabolic improvement, they work best when combined with long-term nutrition, physical activity, behavioral support, sleep optimization, and sustainable lifestyle changes.
Which Weight Loss Medication May Be Right for Me?
The most appropriate weight loss medication depends on several factors, including medical history, metabolic health, eating behaviors, co-occurring conditions, lifestyle goals, medication cost, and tolerance for side effects.
A comprehensive medical evaluation can help determine which approach may offer the safest and most sustainable results.
Comparing Weight Loss Drugs, Supplements, and Pills
Weight loss aids come in various forms, each with distinct characteristics. Therefore, understanding their differences is crucial for making informed decisions.
Weight loss drugs are often prescription-based and regulated for safety and efficacy. In fact, they have undergone rigorous testing to ensure they work as intended.
Supplements, on the other hand, are available over-the-counter and are not regulated by the FDA for efficacy. Unlike prescription drugs, dietary supplements cannot legally claim to treat obesity.
Systematic reviews have consistently found that no dietary supplement has demonstrated clinically meaningful weight loss. Some supplements may also contain adulterated or unsafe ingredients.
Here’s a quick comparison:
• Weight Loss Drugs: Prescription-based, clinically tested, potent effects. Produce 5–21% weight loss depending on the agent.
• Weight Loss Supplements: Available over-the-counter, lack evidence of clinically meaningful weight loss, and may pose safety risks.
Weighing the pros and cons of each option is essential. Before choosing the right product, individuals should consider their personal health needs and consult healthcare professionals.
Integrating Medications with Lifestyle Changes
Weight loss drugs can be powerful allies in the journey toward better health. However, they work best when combined with lifestyle changes.
Incorporating weight loss medications with healthy habits leads to more sustainable results. While medications can jump-start weight loss, long-term success requires comprehensive strategies.
Consider the following integrative approach:
• Nutrition: Emphasize balanced, nutrient-rich meals.
• Exercise: Engage in regular physical activity.
• Behavioral Changes: Address emotional eating through therapy.
Implementing this holistic method fosters not only weight loss but also overall well-being. Moreover, it is essential to tailor these strategies to individual needs, with guidance from healthcare professionals.
The Psychological Impact: Mental Health and Self-Esteem
Weight loss can have effects on mental health. For many individuals, losing weight often leads to improved self-esteem and quality of life. Meta-analyses have found that weight-reducing treatments are associated with reduced risk of depression and improved functional health status.
However, the relationship between weight loss medications and mental health is nuanced and varies by drug class. GLP-1 receptor agonists have shown improvements in mental health-related quality of life in clinical trials.
In contrast, topiramate (a component of phentermine-topiramate) has been associated with increased incidence of depression, and both naltrexone-bupropion and phentermine-topiramate have been linked to increased anxiety in some patients.
Incorporating weight loss drugs can result in:
• Improved quality of life and physical functioning
• Reduced depressive symptoms (particularly with incretin-based therapies)
• Potential mood side effects with certain drug classes (monitor accordingly)
It is crucial to ensure that mental health support accompanies any weight loss journey. By addressing emotional factors, providers can offer a more holistic approach to weight management and mental health improvements.
Weight Loss Medications in Addiction Recovery
Emerging research suggests that some weight loss medications may benefit individuals with co-occurring substance use disorders (SUDs). This overlap likely reflects shared brain pathways involved in appetite, reward, cravings, and metabolic regulation.
All SUD-related uses of anti-obesity medications are currently considered off-label, although clinical trials remain ongoing.
GLP-1 Receptor Agonists
GLP-1 receptor agonists such as semaglutide and liraglutide currently have the strongest emerging evidence in addiction recovery research. For example, a 2026 randomized controlled trial found that semaglutide significantly reduced alcohol consumption in treatment-seeking individuals with alcohol use disorder and obesity.
Large observational studies have also linked GLP-1 receptor agonists with lower rates of alcohol, nicotine, cannabis, cocaine, and opioid-related disorders, along with reduced SUD-related hospitalizations and mortality. However, research outside alcohol use disorder remains early, and additional clinical trials are ongoing.
Naltrexone-Bupropion
Naltrexone-bupropion may offer added benefit for some individuals with obesity and co-occurring SUDs. The combination of injectable naltrexone and oral bupropion has shown benefit for methamphetamine use disorder and was recently included in ASAM/AAAP guidelines for amphetamine-type stimulant use disorder.
The oral Contrave formulation may also be considered for individuals with obesity, depression, nicotine dependence, or alcohol use concerns.
Topiramate
Topiramate, prescribed as monotherapy rather than as part of the phentermine-topiramate combination (Qsymia), has evidence across several conditions relevant to individuals with co-occurring obesity and SUDs.
It has the strongest evidence for alcohol use disorder and is recommended as a first- or second-line treatment in VA/DoD and APA guidelines. Furthermore, topiramate has conditional guideline recommendations for cocaine and methamphetamine use disorders, along with preliminary evidence for smoking cessation.
Topiramate may also reduce binge eating and purging behaviors in binge eating disorder and bulimia nervosa while simultaneously promoting weight loss. As a result, it may offer a uniquely versatile option for individuals with overlapping eating disorders, obesity, and SUDs.
Although topiramate is not FDA-approved as a standalone weight loss medication, it is widely prescribed off-label for weight management.
Patient-Centered Approaches and Family Support
Adopting a patient-centered approach is vital when prescribing weight loss drugs because this strategy involves understanding individual health needs and personal goals. Consequently, customization leads to better adherence and outcomes.
Family support also plays a crucial role in successful weight management. In many cases, the involvement of loved ones can enhance motivation and accountability. Furthermore, it fosters an environment of encouragement and shared effort.
To implement effective support systems, consider:
• Involving family in treatment plans
• Educating families about weight loss strategies
• Encouraging open communication and empathy
Together, patient-centered care and familial involvement can significantly improve the effectiveness of weight loss treatments.
The Future of Weight Loss Medications: Research and Innovation
The future of weight loss medications is promising, with ongoing research driving innovation. New discoveries are focusing on more effective and safer options to aid weight management.
Emerging Trends In The Field
• Triple-agonist therapies approaching weight loss levels previously seen only with bariatric surgery
• Oral formulations that eliminate the need for injections, improving access and patient preference
• Monthly or less frequent dosing options to improve adherence
• Enhanced understanding of how combining different hormonal pathways can optimize weight loss and metabolic health
Weight Loss Medications in the Pipeline
Several promising agents are in late-stage clinical development:
Retatrutide: A triple GIP/GLP-1/glucagon receptor agonist that demonstrated weight loss of approximately 24% at 48 weeks on the 12 mg dose. This is the highest reported for any anti-obesity medication in clinical trials.
CagriSema: A combination of semaglutide and cagrilintide that achieved average weight loss of 20.4% at 68 weeks, with over 40% of fully adherent participants achieving 25% or greater weight reduction.
Survodutide: A dual GLP-1/glucagon receptor agonist that achieved 14.9% weight loss at 46 weeks in a phase 2 trial.
MariTide (maridebart cafraglutide): A monthly injectable monoclonal antibody that inhibits the GIP receptor and is conjugated with GLP-1 analogue peptides. It achieved 16.2% weight loss at 52 weeks, with monthly or less frequent dosing.
These advancements hold potential for more tailored and efficient treatments, thereby contributing to healthier lives worldwide.
Toward Holistic, Compassionate Weight Management
Incorporating weight loss medications into care can offer new opportunities. However, it is important to integrate them with compassionate, patient-centered strategies.
Collaboration among healthcare providers ensures a balanced approach. In turn, this supports both mental well-being and physical health throughout patients’ journeys.
Ultimately, understanding individual needs fosters empowerment and long-term success. Together, healthcare professionals can reshape the landscape of weight management for the better.
Weight Loss Medication Treatment in Sarasota, FL
At Solstice Health & Wellness in Sarasota, we help patients understand their weight loss medication options and determine which approach may be safest and most effective for their individual needs.
At Solstice Health & Wellness, care is coordinated and comprehensive. Services include:
This approach addresses not only weight loss, but also the medical, emotional, and lifestyle factors that support long-term success.
We serve residents of Sarasota, Bradenton, Venice, and North Port across Florida’s Gulf Coast.
If you are seeking prescription weight loss medication treatment in Sarasota, Florida, we are here to help.
Ready To Explore Prescription Weight Loss Options?
Schedule a consultation with our Solstice Health & Wellness team in Sarasota to review your health history, discuss medication options, and create a personalized weight loss plan.
Call or connect with Solstice Health & Wellness in Sarasota today.
Frequently Asked Questions About Weight Loss Drugs
1. What are weight loss drugs?
Weight loss drugs are medications that help support weight management by reducing appetite, increasing fullness, or affecting how the body processes food.
2. Are weight loss medications safe?
Many FDA-approved weight loss medications are safe when prescribed and monitored by a healthcare professional.
3. Do weight loss pills work without lifestyle changes?
Weight loss pills work best when combined with nutrition, physical activity, and behavioral support.
4. What is the difference between weight loss drugs and weight loss supplements?
Prescription weight loss drugs are FDA-approved and clinically tested, while many weight loss supplements are sold over the counter with varying levels of scientific evidence.
5. Can weight loss medications improve overall health?
In some individuals, weight loss medications may help improve obesity-related conditions such as diabetes, high blood pressure, and sleep problems.
6. Which weight loss medication works best?
The best medication depends on your health history, weight loss goals, side effect tolerance, and whether you prefer a pill or injection. In many patients, GLP-1-based medications produce the greatest average weight loss, but the right choice is individualized.
7. Do I have to take injections?
Not always. Some options are weight loss pills, including phentermine, Contrave, orlistat, and orforglipron, while others are weight loss injections such as tirzepatide, semaglutide, and liraglutide.
8. How long do side effects last?
Side effects are often worse when a medication is first started or when the dose is increased. Many people notice improvement as the body adjusts.
9. Can I stop the medication once I lose weight?
Weight regain is common after stopping many weight loss drugs. For some patients, long-term treatment is needed to maintain results.
10. Will insurance cover these medications?
Coverage varies widely depending on the medication, diagnosis, and insurance plan. Some plans cover obesity treatment, while others do not.
Medically Reviewed By
Frank Melo, MD
Board Certified Addiction Medicine and Family Medicine
Medical Director, Solstice Health & Wellness
Last Updated: May 2026
References
- Elmaleh-Sachs A, Schwartz JL, Bramante CT, et al. Obesity Management in Adults: A Review. JAMA. 2023.
- Kushner RF, Jastreboff AM, Ryan DH. Current and Future Medications for Obesity Treatment. JAMA. 2025.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022.
- Wharton S, Lingvay I, Bogdanski P, et al. Oral Semaglutide at a Dose of 25 mg in Adults With Overweight or Obesity (OASIS 4). N Engl J Med. 2025.
- Wharton S, Aronne LJ, Stefanski A, et al. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment (ATTAIN-1). N Engl J Med. 2025.
- U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. 2026.
- U.S. Food and Drug Administration. Foundayo (orforglipron) Prescribing Information. 2026.
- Jastreboff AM, Kaplan LM, Frías JP, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity – A Phase 2 Trial. N Engl J Med. 2023.
- Lingvay I, Cohen RV, le Roux CW, Sumithran P. Obesity in Adults. Lancet. 2024.
- Batsis JA, Apolzan JW, Bagley PJ, et al. A Systematic Review of Dietary Supplements and Alternative Therapies for Weight Loss. Obesity. 2021.
- Nourredine M, Jurek L, Angerville B, et al. Use of Topiramate in the Spectrum of Addictive and Eating Disorders: A Systematic Review. CNS Drugs. 2021
- Liu L, Li Z, Ye W, et al. Safety and Effects of Anti-Obesity Medications on Weight Loss, Cardiometabolic, and Psychological Outcomes in People Living with Overweight or Obesity: A Systematic Review and Meta-Analysis. EClinicalMedicine. 2025.
- Farokhnia M, Leggio L. Prospects of GLP-1 Therapies for Addiction and Mental Health Comorbidities – Quo Vadis?: A Review. JAMA Psychiatry. 2026.
- Trivedi MH, Walker R, Ling W, et al. Bupropion and Naltrexone in Methamphetamine Use Disorder (ADAPT-2). N Engl J Med. 2021.
Medical Disclaimer: The information provided on this page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.